Former Walgreens could become five new retail suites - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 68%

United States News News

United States United States Latest News,United States United States Headlines

It's not the only former downtown drugstore getting creative in a down market.

The owner of a 10,200-square-foot former Walgreens at 740 Market St. has proposed converting the entirety of the space into as many as five retail suites, a potential creative adjustment to a difficult leasing environment downtown.

The conversion would seem to acknowledge the challenge of finding a tenant willing to take on the entirety of the space, which has been vacant since early March 2020. The Walgreens isn’t alone in proposing creative reconfigurations of former drugstore spaces downtown. Across the street from 740 Market St. is 731 Market St., one of six CVS stores that shuttered downtown earlier this year. Another occupying 8,638 square feet at 351 Market St. isFormer Walgreens spaces are being advertised for lease at 141 Kearny St. and 88 Spear St., as well as in the neighborhoods, at 2550 Ocean Ave.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Exelixis puts fat wallet to work with Cybrexa, Sairopa deals - San Francisco Business TimesPresident and CEO Michael Morrissey said the deals tap the company's balance sheet and share risks with its partners.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »

Gritstone Bio, other biotech companies are building drug pipelines with PIPEs - San Francisco Business TimesHow $GRTS and other public biotech companies are quietly raising chunks of capital from select investors PIPEs
Source: SFBusinessTimes - 🏆 78. / 68 Read more »